In the last trading session, 3.06 million shares of the Hoth Therapeutics Inc (NASDAQ:HOTH) were traded, and its beta was 0.73. Most recently the company’s share price was $0.88, and it changed around $0.01 or 1.68% from the last close, which brings the market valuation of the company to $11.63M. HOTH currently trades at a discount to its 52-week high of $3.80, offering almost -331.82% off that amount. The share price’s 52-week low was $0.58, which indicates that the current value has risen by an impressive 34.09% since then.
Hoth Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended HOTH as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
Instantly HOTH has showed a green trend with a performance of 1.68% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.9820 on recent trading dayincreased the stock’s daily price by 10.39%. The company’s shares are currently up 18.25% year-to-date, but still down -6.88% over the last five days. On the other hand, Hoth Therapeutics Inc (NASDAQ:HOTH) is -29.79% down in the 30-day period.
Hoth Therapeutics Inc (HOTH) estimates and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 15.18%. Hoth Therapeutics Inc earnings are expected to increase by 50.00% in 2025, but the outlook is positive 27.42% per year for the next five years.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024. The former held 38.8 shares worth $35280.0, making up 0.56% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 35.55 shares worth around $32320.0, which represents about 0.51% of the total shares outstanding.
